In addition, TFR1 is highly expressed in activated lymphocytes and malignant cells, and TFR1 antibody ch128.1/IgG1 effectively inhibits the activation, growth, and immortalization of EBV+ human B cells as well as the development of these cells into lymphoma-like tumors in immunodeficient mice (63). Here, TFRC is linked to lymphoma.